Novo Nordisk adds Mars CEO as board observer
Source: SeekingAlpha
2026-03-26 11:57:16 ET
More on Novo Nordisk A/S
- Novo Nordisk: The Illusion Of Cheap
- Novo Nordisk - Enough Is Enough: 5 Reasons It's Time To Sell (Rating Downgrade)
- Novo Nordisk: Buying The Dip Before Volume Dominance
- Novo’s China obesity drug posts positive mid-stage trial results
- Novo Nordisk board proposes DKK 7.95 final dividend for 2025, initiates DKK 15B buyback
Read the full article on Seeking Alpha
For further details see:
Novo Nordisk adds Mars CEO as board observer
Nestle SA ADR Reg Shs Ser B
NASDAQ: NSRGY
NSRGY Trading
-0.26% G/L:
$95.75 Last:
139,214 Volume:
$95.47 Open:
NSRGY Latest News
December 09, 2025 07:57:00 am
Purina Announces Donations to Five Leading Veterinary Schools to Foster Advancements in Veterinary Care
November 24, 2025 08:52:00 am
Canine sports documentary series arrives on Peacock to bolster 'dog show' offerings
November 18, 2025 11:04:00 am
Pro Plan Veterinary Announces Partnership with Ease to Raise Awareness of Veterinary Behavioral Support Services
